In vivo exposure to hydroquinone during the early phase of collagen-induced arthritis aggravates the disease


Butantan affiliation
Publication type
Article
Language
English
Appears in Collections:
Metrics
Abstract
Robust correlation between the severity of rheumatoid arthritis (RA) and cigarette smoking has been clinically demonstrated. Nevertheless, cigarette compounds responsible for this toxic effect and their mechanisms have not been described. Considering that hydroquinone (HQ) is an abundant, pro-oxidative compound of the matter particle phase of cigarette smoke, we investigated whether HQ exposure during the initial phase of collagen-induced arthritis (CIA) could aggravate the disease. For this purpose, male Wistar rats were exposed to aerosolized HQ (25 ppm), saline or 5% ethanol solution (HQ vehicle) for 1 h per day during 14 days. CIA was induced through s.c. injection of bovine collagen Type II (0.4 mg/100 µL) at days seven and 14 of exposure. Clinical signs of disease and the cell profile and chemical mediators in the synovial fluid and membrane were analysed at day 35 after the beginning of exposure. HQ exposure aggravated CIA-related paw edema and increased the cell infiltrate and interleukin-6 (IL-6) levels in the synovial fluid, promoted intense tissue collagen deposition and enhanced synoviocyte proliferation and higher frequency of aryl hydrocarbon receptor (AhR+) and interleukin (IL-17+) neutrophils in the synovial membrane. in vitro data also highlighted that neutrophils expressed increased levels of AhR, IL-17 and reactive oxygen species (ROS) generation. However, only AhR expression and ROS generation were blocked by in vitro treatment with AhR antagonist. Therefore, we conclude that in vivo HQ exposure at the early phase of AR onset worsens RA, leading to high frequency of AhR/IL-17+ neutrophils into the joint.
Reference
Heluany CS, Kupa LDVK, Viana MN, Fernandes CM, Silveira ELV, Farsky SHP. In vivo exposure to hydroquinone during the early phase of collagen-induced arthritis aggravates the disease. Toxicology. 2018 Sep;408:22-30. doi:10.1016/j.tox.2018.06.010.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/2532
Journal title
Issue Date
2018


Files in This Item:

Existing users please Login
10.1016j.tox.2018.06.010.pdf
Size: 2.47 MB
Format: Adobe PDF
Embargoed until January 1, 2999    Request a copy
Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.